The latest price target for Vertex Pharmaceuticals (NASDAQ:VRTX) was reported by UBS on November 7, 2025. The analyst firm set a price target for $546.00 expecting VRTX to rise to within 12 months (a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback